
Tan Ho
Examiner (ID: 9184)
| Most Active Art Unit | 2821 |
| Art Unit(s) | 2508, 2514, 3621, 2819, 2845, 2821 |
| Total Applications | 2181 |
| Issued Applications | 1904 |
| Pending Applications | 103 |
| Abandoned Applications | 174 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9223006
[patent_doc_number] => 20140017781
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-16
[patent_title] => 'Methods of Modifying Eukaryotic Cells'
[patent_app_type] => utility
[patent_app_number] => 14/036774
[patent_app_country] => US
[patent_app_date] => 2013-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13206
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14036774
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/036774 | Mouse embryonic stem cells comprising a hybrid heavy chain immunoglobulin locus | Sep 24, 2013 | Issued |
Array
(
[id] => 9268720
[patent_doc_number] => 20140023637
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-23
[patent_title] => 'Methods of Modifying Eukaryotic Cells'
[patent_app_type] => utility
[patent_app_number] => 14/035432
[patent_app_country] => US
[patent_app_date] => 2013-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13205
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14035432
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/035432 | Methods of making a nucleic acid encoding a human variable region | Sep 23, 2013 | Issued |
Array
(
[id] => 9670571
[patent_doc_number] => 20140234434
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-21
[patent_title] => 'Tissue for Prosthetic Implants and Grafts, and Methods Associated Therewith'
[patent_app_type] => utility
[patent_app_number] => 14/032088
[patent_app_country] => US
[patent_app_date] => 2013-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6799
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14032088
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/032088 | Tissue for Prosthetic Implants and Grafts, and Methods Associated Therewith | Sep 18, 2013 | Abandoned |
Array
(
[id] => 9211660
[patent_doc_number] => 20140010837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-09
[patent_title] => 'Methods and Compositions for Preventing a Condition'
[patent_app_type] => utility
[patent_app_number] => 14/024216
[patent_app_country] => US
[patent_app_date] => 2013-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 33727
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14024216
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/024216 | Methods and Compositions for Preventing a Condition | Sep 10, 2013 | Abandoned |
Array
(
[id] => 9383359
[patent_doc_number] => 20140086840
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-27
[patent_title] => 'Therapeutic Antibody Target Validation and Screening In Vivo'
[patent_app_type] => utility
[patent_app_number] => 14/019684
[patent_app_country] => US
[patent_app_date] => 2013-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 20415
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14019684
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/019684 | Therapeutic Antibody Target Validation and Screening In Vivo | Sep 5, 2013 | Abandoned |
Array
(
[id] => 12388422
[patent_doc_number] => 09963715
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-08
[patent_title] => Methods and compositions for treatment of a genetic condition
[patent_app_type] => utility
[patent_app_number] => 14/013236
[patent_app_country] => US
[patent_app_date] => 2013-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 13
[patent_no_of_words] => 27237
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 718
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14013236
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/013236 | Methods and compositions for treatment of a genetic condition | Aug 28, 2013 | Issued |
Array
(
[id] => 9370343
[patent_doc_number] => 20140080216
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-20
[patent_title] => 'METHODS AND COMPOSITIONS FOR TREATMENT OF A GENETIC CONDITION'
[patent_app_type] => utility
[patent_app_number] => 14/013250
[patent_app_country] => US
[patent_app_date] => 2013-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 30131
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14013250
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/013250 | Methods and compositions for treatment of a genetic condition | Aug 28, 2013 | Issued |
Array
(
[id] => 10375696
[patent_doc_number] => 20150260704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-17
[patent_title] => 'GENDER, VIABILITY AND/OR DEVELOPMENTAL STAGE DETERMINATION OF AVIAN EMBRYOS IN OVO'
[patent_app_type] => utility
[patent_app_number] => 14/418506
[patent_app_country] => US
[patent_app_date] => 2013-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5387
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14418506
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/418506 | GENDER, VIABILITY AND/OR DEVELOPMENTAL STAGE DETERMINATION OF AVIAN EMBRYOS IN OVO | Jul 29, 2013 | Abandoned |
Array
(
[id] => 9283367
[patent_doc_number] => 20140033335
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-30
[patent_title] => 'Immunoglobulin 2'
[patent_app_type] => utility
[patent_app_number] => 13/953894
[patent_app_country] => US
[patent_app_date] => 2013-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12943
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13953894
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/953894 | Immunoglobulin 2 | Jul 29, 2013 | Abandoned |
Array
(
[id] => 9148376
[patent_doc_number] => 20130302899
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-14
[patent_title] => 'MULTIFUNCTIONAL ALLELES'
[patent_app_type] => utility
[patent_app_number] => 13/940609
[patent_app_country] => US
[patent_app_date] => 2013-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 20914
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13940609
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/940609 | Multifunctional alleles | Jul 11, 2013 | Issued |
Array
(
[id] => 9434989
[patent_doc_number] => 20140112896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-24
[patent_title] => 'METHODS AND COMPOSITIONS FOR THE PROVISION OF PROTEINS DEFICIENT IN LYSOSOMAL STORAGE DISEASES'
[patent_app_type] => utility
[patent_app_number] => 13/939794
[patent_app_country] => US
[patent_app_date] => 2013-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 27312
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13939794
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/939794 | Method of treating lysosomal storage diseases | Jul 10, 2013 | Issued |
Array
(
[id] => 9181222
[patent_doc_number] => 20130323207
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-05
[patent_title] => 'PRODUCTS AND METHODS FOR DELIVERY OF POLYNUCLEOTIDES BY ADENO-ASSOCIATED VIRUS FOR LYSOSOMAL STORAGE DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 13/922915
[patent_app_country] => US
[patent_app_date] => 2013-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11434
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13922915
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/922915 | PRODUCTS AND METHODS FOR DELIVERY OF POLYNUCLEOTIDES BY ADENO-ASSOCIATED VIRUS FOR LYSOSOMAL STORAGE DISORDERS | Jun 19, 2013 | Abandoned |
Array
(
[id] => 9093696
[patent_doc_number] => 20130273007
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-17
[patent_title] => 'Methods for attenuating virus strains for diagnostic and therapeutic uses'
[patent_app_type] => utility
[patent_app_number] => 13/986866
[patent_app_country] => US
[patent_app_date] => 2013-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 105477
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13986866
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/986866 | Methods for attenuating virus strains for diagnostic and therapeutic uses | Jun 11, 2013 | Abandoned |
Array
(
[id] => 13165651
[patent_doc_number] => 10098917
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-16
[patent_title] => Parovirus having a CpG-enriched genome useful for cancer therapy
[patent_app_type] => utility
[patent_app_number] => 13/887029
[patent_app_country] => US
[patent_app_date] => 2013-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5097
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13887029
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/887029 | Parovirus having a CpG-enriched genome useful for cancer therapy | May 2, 2013 | Issued |
Array
(
[id] => 8992255
[patent_doc_number] => 20130219536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-22
[patent_title] => 'LRRK2 POLYNUCLEOTIDES AND TRANGENIC ANIMALS'
[patent_app_type] => utility
[patent_app_number] => 13/875048
[patent_app_country] => US
[patent_app_date] => 2013-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5560
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13875048
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/875048 | LRRK2 POLYNUCLEOTIDES AND TRANGENIC ANIMALS | Apr 30, 2013 | Abandoned |
Array
(
[id] => 8975993
[patent_doc_number] => 20130209423
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-15
[patent_title] => 'METHODS FOR PROMOTING HEMATOPOIETIC RECONSTITUTION'
[patent_app_type] => utility
[patent_app_number] => 13/836794
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 19440
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13836794
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/836794 | Methods for promoting hematopoietic reconstitution | Mar 14, 2013 | Issued |
Array
(
[id] => 8975994
[patent_doc_number] => 20130209424
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-15
[patent_title] => 'COMPOSITIONS FOR PROMOTING HEMATOPOIETIC STEM CELL GROWTH'
[patent_app_type] => utility
[patent_app_number] => 13/837265
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 19442
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13837265
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/837265 | COMPOSITIONS FOR PROMOTING HEMATOPOIETIC STEM CELL GROWTH | Mar 14, 2013 | Abandoned |
Array
(
[id] => 8989226
[patent_doc_number] => 20130216507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-22
[patent_title] => 'METHODS FOR PROMOTING HSC ENGRAFTMENT'
[patent_app_type] => utility
[patent_app_number] => 13/838002
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 19440
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13838002
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/838002 | Methods for promoting HSC engraftment | Mar 14, 2013 | Issued |
Array
(
[id] => 9042310
[patent_doc_number] => 20130244948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-19
[patent_title] => 'COMPOSITIONS OF CELLS, MEDIA, AND METHODS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/843034
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 13212
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13843034
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/843034 | COMPOSITIONS OF CELLS, MEDIA, AND METHODS THEREOF | Mar 14, 2013 | Abandoned |
Array
(
[id] => 9463374
[patent_doc_number] => 20140127800
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-08
[patent_title] => 'Retinoic Acid Enhanced Human Stem Cell Derived Blood Brain Barrier Model'
[patent_app_type] => utility
[patent_app_number] => 13/793466
[patent_app_country] => US
[patent_app_date] => 2013-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 15811
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13793466
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/793466 | Retinoic acid enhanced human stem cell derived blood brain barrier model | Mar 10, 2013 | Issued |